If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> DERMATOLOGY<br /> ISSN 2054-6211 Vol 5.1 • November 2017 • europeanmedical-journal.com<br /> INSIDE<br /> Review of<br /> EADV 2017<br /> Geneva, Switzerland<br /> Skilarence 30 mg & 120 mg gastro-<br /> resistant tablets Active Ingredient:<br /> Skilarence 30 mg Each gastro-resistant<br /> tablet contains 30 mg dimethyl fumarate.<br /> Also contains 34.2 mg lactose (as<br /> monohydrate). Skilarence 120 mg Each<br /> gastro-resistant tablet contains 120 mg<br /> dimethyl fumarate. Also contains 136.8<br /> mg lactose (as monohydrate). Indication:<br /> For the treatment of moderate to severe<br /> plaque psoriasis in adults in need of<br /> systemic medicinal therapy. Dosage and<br /> Administration: For oral use. To improve<br /> tolerability, it is recommended to begin<br /> treatment with a low initial dose with<br /> subsequent gradual increases. I<a title="EMJ Dermatology 5.1 2017 page 1" href="http://viewer.zmags.com/publication/7666a96d?page=1"> DERMATOLOGY ISSN 2054-6211 </a> <a title="EMJ Dermatology 5.1 2017 page 2" href="http://viewer.zmags.com/publication/7666a96d?page=2"> Skilarence 30 mg & 120 mg gastro- resistant</a> <a title="EMJ Dermatology 5.1 2017 page 3" href="http://viewer.zmags.com/publication/7666a96d?page=3"> The only UK licensed FAE for moderate</a> <a title="EMJ Dermatology 5.1 2017 page 4" href="http://viewer.zmags.com/publication/7666a96d?page=4"> Abbreviated Prescribing Information for Kyntheum®</a> <a title="EMJ Dermatology 5.1 2017 page 5" href="http://viewer.zmags.com/publication/7666a96d?page=5"> Confidence starts with clearance Kyntheum ® (bro</a> <a title="EMJ Dermatology 5.1 2017 page 6" href="http://viewer.zmags.com/publication/7666a96d?page=6"> CONTENTS EDITORIAL BOARD.......................</a> <a title="EMJ Dermatology 5.1 2017 page 7" href="http://viewer.zmags.com/publication/7666a96d?page=7"> DERMATOLOGY • CHRONIC URTICARIA IN CHILDREN: </a> <a title="EMJ Dermatology 5.1 2017 page 8" href="http://viewer.zmags.com/publication/7666a96d?page=8"> EDITORIAL BOARD EDITOR-IN-CHIEF Prof Lawrence F</a> <a title="EMJ Dermatology 5.1 2017 page 9" href="http://viewer.zmags.com/publication/7666a96d?page=9"> DERMATOLOGY AIMS AND SCOPE • The European </a> <a title="EMJ Dermatology 5.1 2017 page 10" href="http://viewer.zmags.com/publication/7666a96d?page=10"> DERMATOLOGY 5.1 NOVEMBER 2017 Director Spencer </a> <a title="EMJ Dermatology 5.1 2017 page 11" href="http://viewer.zmags.com/publication/7666a96d?page=11"> Welcome A cheery welcome to each and every one</a> <a title="EMJ Dermatology 5.1 2017 page 12" href="http://viewer.zmags.com/publication/7666a96d?page=12"> y UCB is a global biopharmaceutical compan </a> <a title="EMJ Dermatology 5.1 2017 page 13" href="http://viewer.zmags.com/publication/7666a96d?page=13"> Foreword Assist Prof Hassan Galadari Uni</a> <a title="EMJ Dermatology 5.1 2017 page 14" href="http://viewer.zmags.com/publication/7666a96d?page=14"> </a> <a title="EMJ Dermatology 5.1 2017 page 15" href="http://viewer.zmags.com/publication/7666a96d?page=15"> EADV ANNUAL CONGRESS 2017 PALEXPO, GENEVA, SWI</a> <a title="EMJ Dermatology 5.1 2017 page 16" href="http://viewer.zmags.com/publication/7666a96d?page=16"> After an unforgettable beginning, the remaining 4</a> <a title="EMJ Dermatology 5.1 2017 page 17" href="http://viewer.zmags.com/publication/7666a96d?page=17"> Combination Treatment Effectively Treats Rosacea </a> <a title="EMJ Dermatology 5.1 2017 page 18" href="http://viewer.zmags.com/publication/7666a96d?page=18"> This study develops a comprehensive and early tre</a> <a title="EMJ Dermatology 5.1 2017 page 19" href="http://viewer.zmags.com/publication/7666a96d?page=19"> ...the WHO stresses the need for national actions</a> <a title="EMJ Dermatology 5.1 2017 page 20" href="http://viewer.zmags.com/publication/7666a96d?page=20"> During a discussion at the EADV congress, D</a> <a title="EMJ Dermatology 5.1 2017 page 21" href="http://viewer.zmags.com/publication/7666a96d?page=21"> of their CD4 cell count. The long-term outcomes o</a> <a title="EMJ Dermatology 5.1 2017 page 22" href="http://viewer.zmags.com/publication/7666a96d?page=22"> Can Artificial Intelligence Diagnose Skin Cancer M</a> <a title="EMJ Dermatology 5.1 2017 page 23" href="http://viewer.zmags.com/publication/7666a96d?page=23"> public; however, the sensitivity and specificity o</a> <a title="EMJ Dermatology 5.1 2017 page 24" href="http://viewer.zmags.com/publication/7666a96d?page=24"> Patients with an IGA 0 score were associated with</a> <a title="EMJ Dermatology 5.1 2017 page 25" href="http://viewer.zmags.com/publication/7666a96d?page=25"> We dermatologists believe that the maximum concen</a> <a title="EMJ Dermatology 5.1 2017 page 26" href="http://viewer.zmags.com/publication/7666a96d?page=26"> A prospective study at 11 European</a> <a title="EMJ Dermatology 5.1 2017 page 27" href="http://viewer.zmags.com/publication/7666a96d?page=27"> © Clinique Laboratories, LLC Pow! De-aging for t</a> <a title="EMJ Dermatology 5.1 2017 page 28" href="http://viewer.zmags.com/publication/7666a96d?page=28"> Hassan Galadari Assistant Professor of Dermatolo</a> <a title="EMJ Dermatology 5.1 2017 page 29" href="http://viewer.zmags.com/publication/7666a96d?page=29"> Teaching is a great calling. Teachers are truly w</a> <a title="EMJ Dermatology 5.1 2017 page 30" href="http://viewer.zmags.com/publication/7666a96d?page=30"> conducted a study in which we looked at universit</a> <a title="EMJ Dermatology 5.1 2017 page 31" href="http://viewer.zmags.com/publication/7666a96d?page=31"> The idea of specialising in the field of dermatolo</a> <a title="EMJ Dermatology 5.1 2017 page 32" href="http://viewer.zmags.com/publication/7666a96d?page=32"> Allison Cowin Professor of Regenerative Medicine</a> <a title="EMJ Dermatology 5.1 2017 page 33" href="http://viewer.zmags.com/publication/7666a96d?page=33"> Q: You are renowned for your work on th</a> <a title="EMJ Dermatology 5.1 2017 page 34" href="http://viewer.zmags.com/publication/7666a96d?page=34"> treatments for patients with wounds and ski</a> <a title="EMJ Dermatology 5.1 2017 page 35" href="http://viewer.zmags.com/publication/7666a96d?page=35"> Psoriasis is complicated, its impacts are unique </a> <a title="EMJ Dermatology 5.1 2017 page 36" href="http://viewer.zmags.com/publication/7666a96d?page=36"> INNOVATION THAT DRIVES YOUR DERMATOLOGICAL F</a> <a title="EMJ Dermatology 5.1 2017 page 37" href="http://viewer.zmags.com/publication/7666a96d?page=37"> The Future of Medicine Versus the Medicine of </a> <a title="EMJ Dermatology 5.1 2017 page 38" href="http://viewer.zmags.com/publication/7666a96d?page=38"> cal/BD foam spray (n=141) cal/BD ointment (n=135)</a> <a title="EMJ Dermatology 5.1 2017 page 39" href="http://viewer.zmags.com/publication/7666a96d?page=39"> Recently, these API have been reformulated into a</a> <a title="EMJ Dermatology 5.1 2017 page 40" href="http://viewer.zmags.com/publication/7666a96d?page=40"> factors of itch, many patients face a vicious cyc</a> <a title="EMJ Dermatology 5.1 2017 page 41" href="http://viewer.zmags.com/publication/7666a96d?page=41"> PsO type/ character • Plaque type • Eruptive • </a> <a title="EMJ Dermatology 5.1 2017 page 42" href="http://viewer.zmags.com/publication/7666a96d?page=42"> and usually relies on a reactive, on-demand</a> <a title="EMJ Dermatology 5.1 2017 page 43" href="http://viewer.zmags.com/publication/7666a96d?page=43"> common among patients and that physicians </a> <a title="EMJ Dermatology 5.1 2017 page 44" href="http://viewer.zmags.com/publication/7666a96d?page=44"> ADVANCING SCIENCE: DRIVING PROGRESS TODAY FO</a> <a title="EMJ Dermatology 5.1 2017 page 45" href="http://viewer.zmags.com/publication/7666a96d?page=45"> New Treatments, New Data: Rethinking Futur</a> <a title="EMJ Dermatology 5.1 2017 page 46" href="http://viewer.zmags.com/publication/7666a96d?page=46"> Patients (%) 100 90 80 70 60 50 40 30 20 10 </a> <a title="EMJ Dermatology 5.1 2017 page 47" href="http://viewer.zmags.com/publication/7666a96d?page=47"> psoriasis.28 In the AMAGINE programme, 52-week fo</a> <a title="EMJ Dermatology 5.1 2017 page 48" href="http://viewer.zmags.com/publication/7666a96d?page=48"> Efficacy endpoint </a> <a title="EMJ Dermatology 5.1 2017 page 49" href="http://viewer.zmags.com/publication/7666a96d?page=49"> Considering comorbidities More than any other </a> <a title="EMJ Dermatology 5.1 2017 page 50" href="http://viewer.zmags.com/publication/7666a96d?page=50"> Which Drug for Which Patient? The Question of Pa</a> <a title="EMJ Dermatology 5.1 2017 page 51" href="http://viewer.zmags.com/publication/7666a96d?page=51"> necessary to inform patient and clinician decisio</a> <a title="EMJ Dermatology 5.1 2017 page 52" href="http://viewer.zmags.com/publication/7666a96d?page=52"> www.fda.gov/downloads/advisorycom- mittees/commit</a> <a title="EMJ Dermatology 5.1 2017 page 53" href="http://viewer.zmags.com/publication/7666a96d?page=53"> Abstract Reviews THE ASSOCIATIONS OF HUMAN</a> <a title="EMJ Dermatology 5.1 2017 page 54" href="http://viewer.zmags.com/publication/7666a96d?page=54"> Abstract Reviews REFERENCES 1. Schmidt E, Zillik</a> <a title="EMJ Dermatology 5.1 2017 page 55" href="http://viewer.zmags.com/publication/7666a96d?page=55"> EADV 2017 REFERENCES 1. Marconi B et al. Pseudox</a> <a title="EMJ Dermatology 5.1 2017 page 56" href="http://viewer.zmags.com/publication/7666a96d?page=56"> Abstract Reviews POMC gene expression 2.0 1.5 </a> <a title="EMJ Dermatology 5.1 2017 page 57" href="http://viewer.zmags.com/publication/7666a96d?page=57"> EADV 2017 REFERENCES </a> <a title="EMJ Dermatology 5.1 2017 page 58" href="http://viewer.zmags.com/publication/7666a96d?page=58"> Abstract Reviews from initial daily PSL ther</a> <a title="EMJ Dermatology 5.1 2017 page 59" href="http://viewer.zmags.com/publication/7666a96d?page=59"> EADV 2017 Cutaneous vasculitis is a clinicopatho</a> <a title="EMJ Dermatology 5.1 2017 page 60" href="http://viewer.zmags.com/publication/7666a96d?page=60"> Abstract Reviews Figure 1: Widespread milia forma</a> <a title="EMJ Dermatology 5.1 2017 page 61" href="http://viewer.zmags.com/publication/7666a96d?page=61"> EADV 2017 COST-EFFECTIVE THERAPEUTIC MODALITIES </a> <a title="EMJ Dermatology 5.1 2017 page 62" href="http://viewer.zmags.com/publication/7666a96d?page=62"> Abstract Reviews 2. Khar S, Singh N. Alopecia ar</a> <a title="EMJ Dermatology 5.1 2017 page 63" href="http://viewer.zmags.com/publication/7666a96d?page=63"> EADV 2017 A B Figure 2: Diffuse and dense neutro</a> <a title="EMJ Dermatology 5.1 2017 page 64" href="http://viewer.zmags.com/publication/7666a96d?page=64"> SPECIAL POSTER FEATURE CERTOLIZUMAB PEG</a> <a title="EMJ Dermatology 5.1 2017 page 65" href="http://viewer.zmags.com/publication/7666a96d?page=65"> <1% of the expected plasma trough concentration </a> <a title="EMJ Dermatology 5.1 2017 page 66" href="http://viewer.zmags.com/publication/7666a96d?page=66"> EDITOR’S PICK The Editor’s pick for</a> <a title="EMJ Dermatology 5.1 2017 page 67" href="http://viewer.zmags.com/publication/7666a96d?page=67"> a) Typical, painful nodular lesions which a</a> <a title="EMJ Dermatology 5.1 2017 page 68" href="http://viewer.zmags.com/publication/7666a96d?page=68"> the proinflammatory state are present, which play </a> <a title="EMJ Dermatology 5.1 2017 page 69" href="http://viewer.zmags.com/publication/7666a96d?page=69"> MANAGEMENT In January 2017, a panel of experts w</a> <a title="EMJ Dermatology 5.1 2017 page 70" href="http://viewer.zmags.com/publication/7666a96d?page=70"> and fibrosis. The wounds are left open to heal by </a> <a title="EMJ Dermatology 5.1 2017 page 71" href="http://viewer.zmags.com/publication/7666a96d?page=71"> Figure 3: Limberg flap coverage of areas of hidrad</a> <a title="EMJ Dermatology 5.1 2017 page 72" href="http://viewer.zmags.com/publication/7666a96d?page=72"> A good functional and aesthetic result has been r</a> <a title="EMJ Dermatology 5.1 2017 page 73" href="http://viewer.zmags.com/publication/7666a96d?page=73"> of hidradenitis suppurativa ameliorates skin infl</a> <a title="EMJ Dermatology 5.1 2017 page 74" href="http://viewer.zmags.com/publication/7666a96d?page=74"> CHRONIC URTICARIA IN CHILDREN: A REVIEW </a> <a title="EMJ Dermatology 5.1 2017 page 75" href="http://viewer.zmags.com/publication/7666a96d?page=75"> of Allergy and Clinical Immunology (EAACI), the E</a> <a title="EMJ Dermatology 5.1 2017 page 76" href="http://viewer.zmags.com/publication/7666a96d?page=76"> patients.16 In another study focussed solely</a> <a title="EMJ Dermatology 5.1 2017 page 77" href="http://viewer.zmags.com/publication/7666a96d?page=77"> is triggered by a rise in temperature of the body</a> <a title="EMJ Dermatology 5.1 2017 page 78" href="http://viewer.zmags.com/publication/7666a96d?page=78"> Hives/angioedema >6 weeks Specfic testing: cold, </a> <a title="EMJ Dermatology 5.1 2017 page 79" href="http://viewer.zmags.com/publication/7666a96d?page=79"> The first-line treatment for CU is antihista</a> <a title="EMJ Dermatology 5.1 2017 page 80" href="http://viewer.zmags.com/publication/7666a96d?page=80"> longer, but this is also a controversial suggesti</a> <a title="EMJ Dermatology 5.1 2017 page 81" href="http://viewer.zmags.com/publication/7666a96d?page=81"> urticaria. Paediatrics and Child Health. 26(7):29</a> <a title="EMJ Dermatology 5.1 2017 page 82" href="http://viewer.zmags.com/publication/7666a96d?page=82"> 55. Generali JA, Cada DJ. Zafirlukast: Chroni</a> <a title="EMJ Dermatology 5.1 2017 page 83" href="http://viewer.zmags.com/publication/7666a96d?page=83"> PSYCHOSOCIAL ISSUES IN DERMATOLOGY Mukku Shiv</a> <a title="EMJ Dermatology 5.1 2017 page 84" href="http://viewer.zmags.com/publication/7666a96d?page=84"> by arresting cells at the G0/1 cycle and induces </a> <a title="EMJ Dermatology 5.1 2017 page 85" href="http://viewer.zmags.com/publication/7666a96d?page=85"> compared with 18.5% in the control group. Guttate</a> <a title="EMJ Dermatology 5.1 2017 page 86" href="http://viewer.zmags.com/publication/7666a96d?page=86"> Impulse Control Disorders Trichotillomania Tricho</a> <a title="EMJ Dermatology 5.1 2017 page 87" href="http://viewer.zmags.com/publication/7666a96d?page=87"> be called Ekbom syndrome. The condition is more c</a> <a title="EMJ Dermatology 5.1 2017 page 88" href="http://viewer.zmags.com/publication/7666a96d?page=88"> 2013;93(4):387-93. 4. Zbytek B et al. Corticotrop</a> <a title="EMJ Dermatology 5.1 2017 page 89" href="http://viewer.zmags.com/publication/7666a96d?page=89"> 53. Yeung CK, Chan HH. Cutaneous adverse eff</a> <a title="EMJ Dermatology 5.1 2017 page 90" href="http://viewer.zmags.com/publication/7666a96d?page=90"> HIDRADENITIS SUPPURATIVA: A RETROSPECTIVE REV</a> <a title="EMJ Dermatology 5.1 2017 page 91" href="http://viewer.zmags.com/publication/7666a96d?page=91"> Stage 1 Abscess formation, single or multiple, wi</a> <a title="EMJ Dermatology 5.1 2017 page 92" href="http://viewer.zmags.com/publication/7666a96d?page=92"> Table 1: Practice tips for managing hidradenitis </a> <a title="EMJ Dermatology 5.1 2017 page 93" href="http://viewer.zmags.com/publication/7666a96d?page=93"> antimicrobials, including tetracyclines </a> <a title="EMJ Dermatology 5.1 2017 page 94" href="http://viewer.zmags.com/publication/7666a96d?page=94"> formulated and pilot tested by the study team. Da</a> <a title="EMJ Dermatology 5.1 2017 page 95" href="http://viewer.zmags.com/publication/7666a96d?page=95"> The mean length of time supervised by the team wa</a> <a title="EMJ Dermatology 5.1 2017 page 96" href="http://viewer.zmags.com/publication/7666a96d?page=96"> area of the general population of patients on h</a> <a title="EMJ Dermatology 5.1 2017 page 97" href="http://viewer.zmags.com/publication/7666a96d?page=97"> hidradenitis suppurativa/acne inversa. J Eur</a> <a title="EMJ Dermatology 5.1 2017 page 98" href="http://viewer.zmags.com/publication/7666a96d?page=98"> DERMOSCOPY OF INFLAMMATORY CONDITIONS: </a> <a title="EMJ Dermatology 5.1 2017 page 99" href="http://viewer.zmags.com/publication/7666a96d?page=99"> Both original and review articles were included. </a> <a title="EMJ Dermatology 5.1 2017 page 100" href="http://viewer.zmags.com/publication/7666a96d?page=100"> to compact orthokeratosis above zones of wedge- </a> <a title="EMJ Dermatology 5.1 2017 page 101" href="http://viewer.zmags.com/publication/7666a96d?page=101"> The evolution of LP lesions can be monitor</a> <a title="EMJ Dermatology 5.1 2017 page 102" href="http://viewer.zmags.com/publication/7666a96d?page=102"> A B C D E F Figure 2: Dermoscop</a> <a title="EMJ Dermatology 5.1 2017 page 103" href="http://viewer.zmags.com/publication/7666a96d?page=103"> are noted; white-coloured, structureless </a> <a title="EMJ Dermatology 5.1 2017 page 104" href="http://viewer.zmags.com/publication/7666a96d?page=104"> seen in acute and chronic stages of eczema</a> <a title="EMJ Dermatology 5.1 2017 page 105" href="http://viewer.zmags.com/publication/7666a96d?page=105"> This dermoscopic finding is explained by the</a> <a title="EMJ Dermatology 5.1 2017 page 106" href="http://viewer.zmags.com/publication/7666a96d?page=106"> CHRONIC URTICARIAL VASCULITIS AND IMMU</a> <a title="EMJ Dermatology 5.1 2017 page 107" href="http://viewer.zmags.com/publication/7666a96d?page=107"> Table 1: Laboratory investigation results at admi</a> <a title="EMJ Dermatology 5.1 2017 page 108" href="http://viewer.zmags.com/publication/7666a96d?page=108"> drops (homatropine-hydrobromide) twice dail</a> <a title="EMJ Dermatology 5.1 2017 page 109" href="http://viewer.zmags.com/publication/7666a96d?page=109"> Figure 2: Urticarial rashes of variable nature th</a> <a title="EMJ Dermatology 5.1 2017 page 110" href="http://viewer.zmags.com/publication/7666a96d?page=110"> Schnitzler syndrome may occasionally receive full</a> <a title="EMJ Dermatology 5.1 2017 page 111" href="http://viewer.zmags.com/publication/7666a96d?page=111"> Our patient presented with urticarial lesions aft</a> <a title="EMJ Dermatology 5.1 2017 page 112" href="http://viewer.zmags.com/publication/7666a96d?page=112"> syndrome with monoclonal IgG kappa </a> <a title="EMJ Dermatology 5.1 2017 page 113" href="http://viewer.zmags.com/publication/7666a96d?page=113"> EUROPEAN MEDICAL JOURNAL provides influential arti</a> <a title="EMJ Dermatology 5.1 2017 page 114" href="http://viewer.zmags.com/publication/7666a96d?page=114"> MIND–BODY INTEGRATIVE TREATMENT OF P</a> <a title="EMJ Dermatology 5.1 2017 page 115" href="http://viewer.zmags.com/publication/7666a96d?page=115"> these clear phenomena have so far been ignored by</a> <a title="EMJ Dermatology 5.1 2017 page 116" href="http://viewer.zmags.com/publication/7666a96d?page=116"> chemical messengers and their receptors, named th</a> <a title="EMJ Dermatology 5.1 2017 page 117" href="http://viewer.zmags.com/publication/7666a96d?page=117"> of their words, speculating what may be </a> <a title="EMJ Dermatology 5.1 2017 page 118" href="http://viewer.zmags.com/publication/7666a96d?page=118"> the dermatologist’s field of action. In case</a> <a title="EMJ Dermatology 5.1 2017 page 119" href="http://viewer.zmags.com/publication/7666a96d?page=119"> the cutaneous immune response: Roles of the HPA a</a> <a title="EMJ Dermatology 5.1 2017 page 120" href="http://viewer.zmags.com/publication/7666a96d?page=120"> Buyer’s Guide • 3GEN, INC./DERMLITE • ABBVIE</a> <a title="EMJ Dermatology 5.1 2017 page 121" href="http://viewer.zmags.com/publication/7666a96d?page=121"> Dermatology • K-SURGERY • LA ROCHE-POSAY • </a> <a title="EMJ Dermatology 5.1 2017 page 122" href="http://viewer.zmags.com/publication/7666a96d?page=122"> SUBSCRIBE TO RECEIVE THE LATEST PUBLICATIONS, NEW</a>